EUVIMEDEUVIMED entdecken
Crossref

UHPLC‐Q‐Orbitrap HRMS‐Based Machine Learning Constructs the Integrated Biomarker Profiling of Type 2 Diabetes and Diabetic Heart Disease

Jianglan Long, Yueyue Wang, Qiushi Fang, Zhe Shi, Zhenzhen Wang, Dan Yan iD

Rapid Communications in Mass Spectrometry · 2026

DOI: 10.1002/rcm.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2026. Verfasst von Jianglan Long und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Biomarkers, Machine Learning, Diabetic Cardiomyopathies. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research, National Natural Science Foundation of China, Beijing Friendship Hospital, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Over 70% of diabetic patients die from cardiovascular disease, in which diabetic heart disease (DHD) is an important cause of death in individuals with type 2 diabetes (T2D). It is hence imperative to explore the simple, rapid, and economical method for diagnosing DHD from T2D.

Methods

T2D and DHD patients were recruited, and their serum samples were used for metabolomic analysis to identify differential metabolites. Logistic regression analysis and receiver operating characteristic curve analysis were performed to identify candidate biomarkers. Moreover, four machine learning methods were used to construct the integrated biomarker profiling (IBP) models with the candidate biomarkers. Gini impurity was employed to select characteristic candidate biomarkers.

Results

Eighty‐four differential metabolites were identified in the serum of 58 T2D and 62 DHD patients. Logistic regression analysis indicated that 17 differential metabolites were protective factors, whereas 39 were risk factors for DHD. Further, 29 differential metabolites were identified as the candidate biomarkers of DHD after receiver operating characteristic curve analysis. After comparing the predictive performance of the four machine learning models, the IBP was constructed based on the eXtreme Gradient Boosting (XGBoost) with six candidate biomarkers, which were sphingomyelin (d18:0/16:1), deoxycholic acid, hexadecanedioic acid, phosphatidylcholine (20:5/18:3), L‐tryptophan, and N‐undecanoylglycine from the ranked results of Gini impurity. The accuracy of the IBP for distinguishing T2D and DHD reached 88.89%, with a 100% accuracy in predicting DHD from T2D patients.

Conclusions

The IBP, composed of six metabolites, can effectively predict DHD from T2D, and it is expected to become a screening indicator for early‐stage DHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2BiomarkersMachine LearningDiabetic CardiomyopathiesHumansChromatography, High Pressure LiquidMiddle AgedFemaleMaleMetabolomicsMass SpectrometryAgedROC CurveLogistic Models

Stichwörter der Autor:innen

XGBoostdiabetic heart diseaseintegrated biomarker profilingmachine learningtype 2 diabetes

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Beijing Key Laboratory of Clinical-Based Innovative Drug R&D of Traditional Chinese Medicine, Beijing, China.

ORCID-Profile: Dan Yan

Förderung

  • Capital's Funds for Health Improvement and Research
  • National Natural Science Foundation of China
  • Beijing Friendship Hospital, Capital Medical University

Zitieren

APA

Long, J., Wang, Y., Fang, Q., Shi, Z., Wang, Z., & Yan, D. (2026). UHPLC‐Q‐Orbitrap HRMS‐Based Machine Learning Constructs the Integrated Biomarker Profiling of Type 2 Diabetes and Diabetic Heart Disease. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.70044

Vancouver

Long J, Wang Y, Fang Q, Shi Z, Wang Z, Yan D. UHPLC‐Q‐Orbitrap HRMS‐Based Machine Learning Constructs the Integrated Biomarker Profiling of Type 2 Diabetes and Diabetic Heart Disease. Rapid Communications in Mass Spectrometry. 2026. doi:10.1002/rcm.70044

BibTeX
@article{Long2026,
  author = {Long, Jianglan and Wang, Yueyue and Fang, Qiushi and Shi, Zhe and Wang, Zhenzhen and Yan, Dan},
  title = {UHPLC‐Q‐Orbitrap HRMS‐Based Machine Learning Constructs the Integrated Biomarker Profiling of Type 2 Diabetes and Diabetic Heart Disease},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2026},
  doi = {10.1002/rcm.70044}
}
Kostenlos starten →